SEC Filing Summary: Tharimmune, Inc. (THAR)
Business Context and Reporting Period
This Form 8-K, dated May 14, 2024, reports the results of Tharimmune, Inc.'s Annual Meeting of Stockholders held on the same date. The company is a Delaware corporation listed on The Nasdaq Stock Market LLC under the symbol "THAR" and is classified as an emerging growth company. A total of 4,947,264 shares were represented at the meeting, constituting a quorum.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.
Material Changes and Voting Results
Four proposals were submitted to stockholders, all of which were approved:
- Proposal 1 (Director Elections): All five nominees (Randy Milby, Leonard Mazur, Lynne A. Bui, Sireesh Appajosyula, and Kelly Anderson) were elected. Each received over 2.8 million votes "For" with zero votes "Against."
- Proposal 2 (Auditor Ratification): Stockholders ratified the appointment of Rosenberg Rich Baker Berman P.A. as the independent registered public accounting firm for the fiscal year ended December 31, 2024.
- Proposal 3 (Reverse Stock Split Authority): Stockholders granted the Board discretionary authority to effect a reverse stock split at a ratio between 1-for-2 and 1-for-50. The authority must be exercised, if at all, by May 14, 2025. Fractional shares will be rounded up to the next whole number.
- Proposal 4 (Equity Incentive Plan): The Tharimmune, Inc. Amended and Restated 2023 Omnibus Equity Incentive Plan was approved.
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, management commentary on future operations, or a discussion of risks and contingencies beyond the standard disclosure of the reverse stock split authority.
Key Facts for Investor Verification
- Verify the current trading price and volume of THAR to assess the market's reaction to the approved reverse stock split authority.
- Monitor future filings to determine if and when the Board exercises the authority to execute a reverse stock split.
- Review the Definitive Proxy Statement filed on March 21, 2024, for detailed biographical information on the newly elected directors.
- Check subsequent financial reports (10-Q or 10-K) for the company's actual financial performance, as this 8-K contains no financial data.